Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis
通过抗CD20单链抗体将miR155抑制剂递送至B细胞，可减少乙酰胆碱受体特异性自身抗体，并改善实验性自身免疫性重症肌无力。
期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1111/cei.12265
Wang, Y-Z; Tian, F-F; Yan, M; Zhang, J-M; Liu, Q; Lu, J-Y; Zhou, W-B; Yang, H; Li, J
B细胞
重症肌无力
信号转导
CD20
细胞生物学
CD2
免疫/内分泌
